P Passa

6.2k total citations · 1 hit paper
83 papers, 4.5k citations indexed

About

P Passa is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, P Passa has authored 83 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in P Passa's work include Diabetes Treatment and Management (20 papers), Diabetes Management and Research (15 papers) and Metabolism, Diabetes, and Cancer (11 papers). P Passa is often cited by papers focused on Diabetes Treatment and Management (20 papers), Diabetes Management and Research (15 papers) and Metabolism, Diabetes, and Cancer (11 papers). P Passa collaborates with scholars based in France, United States and Mali. P Passa's co-authors include Michel Marre, Philippe Froguel, Joël Ménard, Gilles Châtellier, Gilberto Velho, Hélène Leblanc, Hélène Blanché, Daniel Cohen, Nathalie Vionnet and Martine Vaxillaire and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

P Passa

77 papers receiving 4.3k citations

Hit Papers

Familial Hyperglycemia Due to Mutations in Glucokinase --... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Passa France 29 2.0k 1.4k 1.0k 883 778 83 4.5k
Susan E. Manley United Kingdom 21 3.5k 1.8× 1.1k 0.8× 1.6k 1.5× 773 0.9× 992 1.3× 51 5.8k
R. Nosadini Italy 38 1.7k 0.9× 1.0k 0.7× 714 0.7× 773 0.9× 343 0.4× 134 4.3k
C A Cull United Kingdom 24 2.9k 1.4× 755 0.5× 680 0.7× 633 0.7× 512 0.7× 37 4.4k
Roberto Trevisan Italy 38 2.7k 1.3× 1.3k 0.9× 880 0.9× 771 0.9× 551 0.7× 126 5.3k
Sally M. Marshall United Kingdom 33 1.4k 0.7× 841 0.6× 637 0.6× 532 0.6× 536 0.7× 93 3.3k
Rudolf W. Bilous United Kingdom 22 1.4k 0.7× 504 0.4× 652 0.6× 1.0k 1.2× 643 0.8× 36 4.1k
Mark E. Cooper Australia 34 1.0k 0.5× 861 0.6× 443 0.4× 1.4k 1.5× 428 0.6× 67 4.6k
Christos Tikellis Australia 25 1.2k 0.6× 1.3k 0.9× 531 0.5× 1.1k 1.2× 257 0.3× 30 3.7k
Sianna Panagiotopoulos Australia 35 1.6k 0.8× 843 0.6× 362 0.4× 711 0.8× 215 0.3× 81 4.2k
Günter Wolf Germany 34 722 0.4× 1.1k 0.8× 448 0.4× 1.6k 1.8× 274 0.4× 70 4.5k

Countries citing papers authored by P Passa

Since Specialization
Citations

This map shows the geographic impact of P Passa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Passa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Passa more than expected).

Fields of papers citing papers by P Passa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Passa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Passa. The network helps show where P Passa may publish in the future.

Co-authorship network of co-authors of P Passa

This figure shows the co-authorship network connecting the top 25 collaborators of P Passa. A scholar is included among the top collaborators of P Passa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Passa. P Passa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guerci, Bruno, Pierre Drouin, Valerie Grange, et al.. (2003). Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes & Metabolism. 29(6). 587–594. 207 indexed citations
2.
Passa, P. (1998). Reducing the cardiovascular consequences of diabetes mellitus. Diabetic Medicine. 15(S4). S69–S72. 4 indexed citations
3.
James, Richard W., Philippe Dussoix, Hélène Blanché, et al.. (1997). Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.. Journal of Clinical Investigation. 99(1). 62–66. 405 indexed citations
4.
Marre, Michel, Xavier Jeunemaı̂tre, Yves Gallois, et al.. (1997). Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.. Journal of Clinical Investigation. 99(7). 1585–1595. 251 indexed citations
5.
Krempf, Michel, et al.. (1997). Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.. PubMed. 23(2). 131–6. 5 indexed citations
6.
Zouali, Habib, Anne Philippi, Nathalie Vionnet, et al.. (1996). Indication for genetic linkage of the phosphoenolpyruvate carboxykinase (PCK1) gene region on chromosome 20q to non-insulin-dependent diabetes mellitus.. PubMed. 22(6). 451–4. 18 indexed citations
7.
Passa, P. (1995). Néphropathie diabétique : intérêt des inhibiteurs de l'enzyme de conversion. Sang thrombose vaisseaux. 7(5). 291–295. 1 indexed citations
8.
Mogensen, Carl Erik, William F. Keane, Peter H. Bennett, et al.. (1995). Prevention of diabetic renal disease with special reference to microalbuminuria. The Lancet. 346(8982). 1080–1084. 404 indexed citations
9.
Papoz, L, J Hors, R Assan, et al.. (1991). Probability of remission in individual in early adult insulin dependent diabetic patients. Results from the Cyclosporine Diabetes French Study Group.. PubMed. 16(4). 303–10. 7 indexed citations
10.
Marre, Michel, Gilles Châtellier, Hélène Leblanc, et al.. (1988). Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.. BMJ. 297(6656). 1092–1095. 284 indexed citations
11.
Leblanc, Hélène, et al.. (1987). [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].. PubMed. 13(6). 613–7. 6 indexed citations
12.
Lombrail, Pierre, et al.. (1986). [Hospital care of insulin-treated diabetes in African immigrants, in France].. PubMed. 12(1). 16–20. 5 indexed citations
13.
Abadie, Éric, et al.. (1985). [Effects of nifedipine on carbohydrate metabolism in the non-insulin dependent diabetic].. PubMed. 11(3). 141–6. 1 indexed citations
14.
Abadie, Éric & P Passa. (1984). Diabetogenic effects of nifedipine. BMJ. 289(6442). 438.1–438. 15 indexed citations
15.
Lombrail, Pierre, et al.. (1983). [Influence of arterial hypertension on diabetic retinopathy].. PubMed. 9(4). 297–302. 3 indexed citations
16.
Jl, Wautier, et al.. (1983). Factors involved in cell adhesion to vascular endothelium.. PubMed. 9(2). 221–34. 18 indexed citations
17.
Passa, P, et al.. (1979). Effets de l'aceébutolol sur les réactions endocriniennes et métaboliques induites par une hypoglycémie aiguë. Etude chez des sujets normaux et des diabétiques insulino-dépendants.. ˜La œNouvelle presse médicale. 8(48).
18.
Passa, P, et al.. (1979). [The effects of acebutolol on endocrine and metabolic reactions induced by acute hypoglycaemia. Study in normal subjects and in insulin-dependent diabetics (author's transl)].. PubMed. 8(48). 3951–5. 1 indexed citations
19.
Lipinski, Michael J., et al.. (1978). [Idiopathic hemochromatosis linkage with the HLA system (author's transl)].. PubMed. 4(2). 109–15. 1 indexed citations
20.
Bensoussan, Danièle, S Lévy-Toledano, P Passa, Jacques Caen, & J Canivet. (1975). Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia. 11(4). 307–312. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026